Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nicholas Marston, M.D.


Harvard School of Public Health, Boston, MAMPH05/2020Clinical Effectiveness
TIMI Study Group, Boston, MA06/2020Clinical Trials
Brigham and Women's Hospital, Boston, MA06/2020Cardiovascular Genetics
Brigham and Women's Hospital, Boston, MA06/2019Cardiovascular Medicine
University of California San Diego, San Diego, CA06/2016Chief Medical Residency
University of California San Diego, San Diego, CA06/2015Internal Medicine
University of Minnesota Medical School, Minneapolis, MNMD05/2012Medicine
University of Texas at Austin, Austin, TXBS05/2007Psychology

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K08HL153950 (MARSTON, NICHOLAS) Jul 15, 2020 - Jun 30, 2025
    Discovery and Application of Germline and Somatic Mutations for Risk Prediction and Personalized Therapy to Prevent Recurrent Myocardial Infarction
    Role: Principal Investigator
  2. F32HL144029 (MARSTON, NICHOLAS) Jul 24, 2018 - Jul 23, 2021
    Creating Genetic Risk Scores to Predict Secondary Coronary Events, Response to Ezetimibe Therapy, and Development of Diabetes after Acute Coronary Syndrome
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. O'Donoghue ML, Marston NA. Time for a paradigm shift? Making the case for tailored selection of antiplatelet therapy. Eur Heart J. 2022 03 07; 43(10):968-970. PMID: 35166344.
    Citations:    Fields:    
  2. Marston NA, Giugliano RP, Melloni GEM, Park JG, Morrill V, Blazing MA, Ference B, Stein E, Stroes ES, Braunwald E, Ellinor PT, Lubitz SA, Ruff CT, Sabatine MS. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content. JAMA Cardiol. 2022 Mar 01; 7(3):250-256. PMID: 34773460.
    Citations:    Fields:    
  3. O'Donoghue ML, Marston NA. Risk factors for type 2 MI: the usual suspects or guilt by association? Eur Heart J. 2022 01 13; 43(2):136-137. PMID: 34599595.
    Citations:    Fields:    
  4. Paruchuri K, Finneran P, Marston NA, Healy EW, Andreo J, Lynch R, Blood AJ, Jones-O'Connor M, Lander B, Kelly N, Vivaldi MT, Traynor K, Wiviott S, Natarajan P. Outcomes of a smartphone-based application with live health-coaching post-percutaneous coronary intervention. EBioMedicine. 2021 Oct; 72:103593. PMID: 34657825.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  5. Marston NA, Giugliano RP, Park JG, Ruzza A, Sever PS, Keech AC, Sabatine MS. Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL. Circulation. 2021 11 23; 144(21):1732-1734. PMID: 34452583.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  6. Marston NA, Oyama K, Jarolim P, Tang M, Sever PS, Keech AC, Lira Pineda A, Wang H, Giugliano RP, Sabatine MS, Morrow DA. Combining High-Sensitivity Troponin With the American Heart Association/American College of Cardiology Cholesterol Guidelines to Guide Evolocumab Therapy. Circulation. 2021 07 20; 144(3):249-251. PMID: 34279993.
    Citations:    Fields:    Translation:Humans
  7. O'Donoghue ML, Marston NA. The Role of Adipose Tissue in Cardiovascular Disease: Decoding its Secret Language. J Am Coll Cardiol. 2021 05 25; 77(20):2514-2516. PMID: 34016264.
    Citations:    Fields:    Translation:Humans
  8. Marston NA, Han L, Olivotto I, Day SM, Ashley EA, Michels M, Pereira AC, Ingles J, Semsarian C, Jacoby D, Colan SD, Rossano JW, Wittekind SG, Ware JS, Saberi S, Helms AS, Ho CY. Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy. Eur Heart J. 2021 05 21; 42(20):1988-1996. PMID: 33769460.
    Citations: 5     Fields:    Translation:Humans
  9. Marston NA, Melloni GEM, Gurmu Y, Bonaca MP, Kamanu FK, Roselli C, Lee C, Cavallari I, Giugliano RP, Scirica BM, Bhatt DL, Steg PG, Cohen M, Storey RF, Keech AC, Raz I, Mosenzon O, Braunwald E, Lubitz SA, Ellinor PT, Sabatine MS, Ruff CT. Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease. Circ Genom Precis Med. 2021 02; 14(1):e003006. PMID: 33434447.
    Citations: 1     Fields:    Translation:Humans
  10. Marston NA, Patel PN, Kamanu FK, Nordio F, Melloni GM, Roselli C, Gurmu Y, Weng LC, Bonaca MP, Giugliano RP, Scirica BM, O'Donoghue ML, Cannon CP, Anderson CD, Bhatt DL, Gabriel Steg P, Cohen M, Storey RF, Sever P, Keech AC, Raz I, Mosenzon O, Antman EM, Braunwald E, Ellinor PT, Lubitz SA, Sabatine MS, Ruff CT. Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease. Circulation. 2021 02 02; 143(5):470-478. PMID: 33185476.
    Citations: 4     Fields:    Translation:Humans
  11. Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, Braunwald E, Giugliano RP, Sabatine MS. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2020 11 21; 396(10263):1637-1643. PMID: 33186535.
    Citations: 18     Fields:    Translation:Humans
  12. Marston NA, Bonaca MP, Jarolim P, Goodrich EL, Bhatt DL, Steg PG, Cohen M, Storey RF, Johanson P, Wiviott SD, Braunwald E, Sabatine MS, Morrow DA. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines. JAMA Cardiol. 2020 11 01; 5(11):1255-1262. PMID: 32756916.
    Citations: 2     Fields:    Translation:Humans
  13. Marston NA, Ruff CT, Sabatine MS. Response by Marston et al to Letter Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism". Circulation. 2020 10 27; 142(17):e264. PMID: 33104403.
    Citations:    Fields:    Translation:Humans
  14. Marston NA, Gurmu Y, Melloni GEM, Bonaca M, Gencer B, Sever PS, Pedersen TR, Keech AC, Roselli C, Lubitz SA, Ellinor PT, O'Donoghue ML, Giugliano RP, Ruff CT, Sabatine MS. The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism. Circulation. 2020 05 19; 141(20):1600-1607. PMID: 32223429.
    Citations: 19     Fields:    Translation:Humans
  15. Marston NA, Kamanu FK, Nordio F, Gurmu Y, Roselli C, Sever PS, Pedersen TR, Keech AC, Wang H, Lira Pineda A, Giugliano RP, Lubitz SA, Ellinor PT, Sabatine MS, Ruff CT. Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial. Circulation. 2020 02 25; 141(8):616-623. PMID: 31707849.
    Citations: 29     Fields:    Translation:Humans
  16. Marston NA, Giugliano RP, Im K, Silverman MG, O'Donoghue ML, Wiviott SD, Ference BA, Sabatine MS. Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials. Circulation. 2019 10 15; 140(16):1308-1317. PMID: 31530008.
    Citations: 28     Fields:    Translation:Humans
  17. Penn EH, Olenchock BA, Marston NA. A Shocking Deficiency. Circulation. 2019 08 13; 140(7):613-617. PMID: 31403849.
    Citations: 5     Fields:    Translation:Humans
  18. Beri N, Marston NA, Daniels LB, Nowak RM, Schreiber D, Mueller C, Jaffe A, Diercks DB, Wettersten N, DeFilippi C, Peacock WF, Limkakeng AT, Anand I, McCord J, Hollander JE, Wu AHB, Apple FS, Nagurney JT, Berardi C, Cannon CM, Clopton P, Neath SX, Christenson RH, Hogan C, Vilke G, Maisel A. Necessity of hospitalization and stress testing in low risk chest pain patients. Am J Emerg Med. 2017 Feb; 35(2):274-280. PMID: 27847253.
    Citations: 2     Fields:    Translation:Humans
  19. Marston NA, Shah KS, Mueller C, Neath SX, Christenson RH, McCord J, Nowak RM, Daniels LB, Hollander JE, Apple F, Nagurney J, Schreiber D, deFilippi C, Diercks D, Limkakeng A, Anand IS, Wu AH, Jaffe AS, Peacock WF, Maisel AS. Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial. Emerg Med J. 2016 Jan; 33(1):23-9. PMID: 26105583.
    Citations: 3     Fields:    Translation:Humans
  20. Shah KS, Marston NA, Mueller C, Neath SX, Christenson RH, McCord J, Nowak RM, Vilke GM, Daniels LB, Hollander JE, Apple FS, Cannon CM, Nagurney J, Schreiber D, deFilippi C, Hogan CJ, Diercks DB, Limkakeng A, Anand IS, Wu AH, Clopton P, Jaffe AS, Peacock WF, Maisel AS. Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial. Acad Emerg Med. 2015 May; 22(5):554-63. PMID: 25908114.
    Citations: 4     Fields:    Translation:Humans
  21. Marston N, Brown JP, Olson N, Auger WR, Madani MM, Wong D, Raisinghani AB, DeMaria AN, Blanchard DG. Right ventricular strain before and after pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Echocardiography. 2015 Jul; 32(7):1115-21. PMID: 25327878.
    Citations: 6     Fields:    Translation:Humans
  22. Marston NA, Maisel AS. The prognostic value of copeptin in patients with acute chest pain. Expert Rev Cardiovasc Ther. 2014 Oct; 12(10):1237-42. PMID: 25244624.
    Citations:    Fields:    Translation:Humans
  23. Marston NA, Auger WR, Madani MM, Kimura BJ, Strachan GM, Raisinghani AB, DeMaria AN, Blanchard DG. Assessment of left atrial volume before and after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension. Cardiovasc Ultrasound. 2014 Aug 11; 12:32. PMID: 25109313.
    Citations: 5     Fields:    Translation:Humans
  24. Marston N, Sandoval Y, Zakharova M, Brenes-Salazar J, Santili S, Adabag S, McFalls EO, Garcia S. Troponin elevations following vascular surgery in patients without preoperative myocardial ischemia. South Med J. 2013 Nov; 106(11):612-7. PMID: 24192592.
    Citations: 2     Fields:    Translation:Humans
  25. Marston N, Kehl D, Copp J, Nourbakhsh N, Rifkin DE. Alkalotics anonymous: severe metabolic alkalosis. Am J Med. 2014 Jan; 127(1):25-7. PMID: 24268303.
    Citations:    Fields:    Translation:Humans
  26. Garcia S, Marston N, Sandoval Y, Pierpont G, Adabag S, Brenes J, Santilli S, McFalls EO. Prognostic value of 12-lead electrocardiogram and peak troponin I level after vascular surgery. J Vasc Surg. 2013 Jan; 57(1):166-72. PMID: 22975335.
    Citations: 9     Fields:    Translation:HumansCells
  27. Marston N, Brenes J, Garcia S, Kuskowski M, Adabag S, Santilli S, McFalls EO. Peak postoperative troponin levels outperform preoperative cardiac risk indices as predictors of long-term mortality after vascular surgery Troponins and postoperative outcomes. J Crit Care. 2012 Feb; 27(1):66-72. PMID: 21798697.
    Citations: 4     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Marston's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (128)
Co-Authors (28)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.